Background

The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) has collected data on over 1 million patients since it came online in 2015. The MBSAQIP reports on over 200,000 de-identified cases from 902 participating centers to the MBSQIP data registry yearly. Our objective was to examine the impact of the MBSAQIP on the surgical literature.

Methods

PubMed was queried using keywords “MBSAQIP” and “Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.” Letters to editors, duplicates, commentaries, and retracted articles were excluded. Studies that mentioned MBSAQIP but did not use the PUF were also excluded.

Results

A total of 340 items were returned. After exclusions, 241 studies were reviewed. Fifteen articles were noted to have used MBSAQIP to create or modify risk calculators/ predictive models. 26 were on robotic surgery and 14 compared procedures. 24 papers evaluated patient characteristics and outcomes, 17 discussed outcomes and racial disparities. 15 studies looked at outcomes by age, and 5 by BMI. There were 17 on complications. 11 studies were on revisions/conversions. 10 studied sleeve gastrectomy specifically. There were 11 total on OAGB, DS/SADI and ESG. Seven were on GERD/hiatal hernia. Six papers evaluated DVT/PE.

Conclusions

The MBSAQIP is a valuable resource that has generated a wealth of studies in the literature. It has allowed for intense analysis of clinical issues and fostered a culture of safety and quality improvement.